Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial Development of new treatments for gonorrhoea is a global public health priority. We aimed to evaluate the efficacy and safety of zoliflodacin versus c…

The GGD Amsterdam was part of the #Zolflodacin gonorrhoea treatment trial. I am proud to present the results in the Lancet publication! Resistant strains increasingly narrow treatment options. Zoliflodacin will help to control the rise in #gonorrhoea infections. www.sciencedirect.com/science/arti...